- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02830698
Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance
Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance. A Prospective Single-center Study
Abdominal pain disorders functional (including functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain) is a very common disease in the pediatric population, where classical medical treatment does not always prove effective. This clinical entity has an impact on the individual physiological balance particularly on the autonomic regulation. Studies concerning adults with irritable bowel syndrome, showed significant changes in heart rate variability indices (HRV: heart rate variability).
The study of time and frequency domain analysis of HRV allows noninvasive and reproducible assessment of the cardiac sympathetic and parasympathetic tone.
The investigators hypothesize that the sympathovagal balance could be altered in children in case of prolonged nociceptive stress as the investigators find it especially in irritable bowel syndrome and functional abdominal pain. In recent years, the control of pediatric pain experienced considerable growth through hypnosis techniques and several studies have shown analgesic efficacy with a beneficial effect in terms of quality of life in children.
Our study aims to assess the impact of the hypno-analgesia treatment of Abdominal pain disorders functional on sympathovagal balance. The investigators propose to realize in 7 to 18 years old children with Abdominal pain disorders functional a single center prospective study to highlight after a standardized hypnosis program, changes in the time and frequency domain indices of heart rate variability and clinical or quality of life parameters. The primary endpoint will be the high frequency HF indice. Secondary endpoints will be the other indices of HRV (Ptot, VLF, LF, ratio LF / HF, SDNN, SDANN, pNN50, RMSSD), the Quality of Life Questionnaire values (PedsQL ™ 4.0) a pain scale and the composite score of Francis.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Saint Etienne, France, 42055
- Centre Hospitalier Universitaire de Saint Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Parents affiliates or entitled to a social security scheme
- Consent form signed by the holder of parental authority
Exclusion Criteria:
- Child with pathologies reaching the central nervous system or the brain stem.
- Children with a severe pathology of cardio-respiratory or heart being referred to treatment.
- Children requiring emergency surgery or trauma or septic or inflammatory context.
- Children with psychiatric disorders or mental retardation proven.
- Children who have already used the earlier hypnosis.
- Children not speaking French language.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
high frequency
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
composite score of Francis
Time Frame: One month after the hypno-analgesic therapeutic program
|
severity scale of syndrome (pain intensity)
|
One month after the hypno-analgesic therapeutic program
|
Pediatric Quality of Life inventory
Time Frame: One month after the hypno-analgesic therapeutic program
|
One month after the hypno-analgesic therapeutic program
|
|
a chronic abdominal pain scale
Time Frame: One month after the hypno-analgesic therapeutic program
|
adaptation of Francis composite scale for chronic abdominal pain
|
One month after the hypno-analgesic therapeutic program
|
a severity of functional dyspepsia scale
Time Frame: One month after the hypno-analgesic therapeutic program
|
adaptation of Francis composite scale for functional dyspepsia
|
One month after the hypno-analgesic therapeutic program
|
a severity of abdominal migraine scale
Time Frame: One month after the hypno-analgesic therapeutic program
|
adaptation of Francis composite scale for abdominal migraine
|
One month after the hypno-analgesic therapeutic program
|
SDNN (standard deviation of all NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
SDANN (standard deviation of the averages of NN intervals in all 5 min segments of the entire recording)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
RMSSD (the square root of the mean of the sum of the squares of difference between adjacent NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
pNN50 (the number of pairs of adjacent NN intervals differing by more than 50 ms dived by the total number of all NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
TP (total power)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
VLF (very low frequency component)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
LF (low frequency component)
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
ratio LF/ HF
Time Frame: One month after the hypno-analgesic therapeutic program
|
measured with the holter
|
One month after the hypno-analgesic therapeutic program
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hugues PATURAL, MD PhD, Centre Hospitalier Universitaire de Saint Etienne
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1608081
- 2016-A00868-43 (OTHER: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Pain
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Abdominal Pain (AP)
-
Duke UniversityUnknown
-
Children's Mercy Hospital Kansas CityUniversity of ArizonaCompletedFunctional Abdominal Pain
-
University of WashingtonUniversity of North Carolina; MultiCare Mary Bridge Children's Hospital & Health...Completed
-
University of MichiganTerminatedFunctional Abdominal PainUnited States
-
University of BariClinica PEdiatrica Ospedale San Paolo Bari ItalyCompletedFunctional Abdominal PainItaly
-
National Center for Complementary and Integrative...CompletedRecurrent Abdominal PainUnited States
-
Jacques E. ChellyNational Institute on Drug Abuse (NIDA); Masimo CorporationRecruitingOpioid Use | Cancer Pain | Auriculotherapy | Pain, AbdominalUnited States
-
Michigan State UniversitySpectrum Health HospitalsWithdrawnFunctional Abdominal Pain SyndromeUnited States
-
Region Örebro CountyÖrebro University, SwedenActive, not recruitingFunctional Abdominal Pain | IBSSweden